Oncternal Therapeutics shares owned by Bank of America Corporation
Quarter-by-quarter ownership of Oncternal Therapeutics shares owned by Bank of America Corporation
from 13F filings
Historical chart of Bank of America Corporation investment in Oncternal Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Oncternal Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Oncternal Therapeutics by Bank of America Corporation
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $19 | 35 | 0.54 |
| 2023-09-30 | $1.8k | 6.0k | 0.30 |
| 2023-06-30 | $2.1k | 6.0k | 0.35 |
| 2023-03-31 | $6.3k | 8.0k | 0.79 |
| 2022-12-31 | $7.1k | 7.1k | 1.00 |
| 2022-06-30 | $15k | 13k | 1.14 |
| 2021-12-31 | $148k | 66k | 2.26 |
| 2021-06-30 | $263k | 55k | 4.75 |
| 2021-03-31 | $167k | 20k | 8.31 |
| 2020-12-31 | $29k | 6.0k | 4.83 |
| 2020-09-30 | $10k | 6.0k | 1.67 |
| 2020-06-30 | $17k | 6.0k | 2.83 |
| 2020-03-31 | $15k | 5.0k | 3.00 |
| 2019-12-31 | $40k | 10k | 3.99 |
| 2019-09-30 | $112k | 22k | 4.99 |
More positions owned by Bank of America Corporation
View all positions for Bank of America Corporation